1.Application of color velocity imaging-quantitative method in cerebral infarction
Qi ZHANG ; Jian-Hua XIE ; Xiao-Li LÜ
Academic Journal of Second Military Medical University 2001;22(4):303-305
Objective: To evaluate color velocity imaging-quantitative method (CVI-Q) in estimating cerebral hemodynamic change in patients with cerebral infarction. Methods: The carotids of 60 normal people and 40 cerebral infarction patients were detected by CVI-Q. We observed endangium thickness and atheromatous plaques,and measured the diameter (d), peak velocity(Vmax), resistance index(RI) and blood flow volume(Q) of the common carotid arteries. Results: In cerebral infarction group there were 75% cases with endangium thickening to different degrees, 45% cases with atheromatous plaques and 71% plaques in carotid enlargement section or bifurcation. The data measured in 2 groups were compared: (1)The d value in cerebral infarction cases increased than that in normal(P<0.05 or P<0.01); (2)The Vmax reduced in cerebral infarction cases(P<0.05); (3)The RI increased in cerebral infarction cases (P<0.05 or P< 0.01); (4) The Q value reduced in cerebral infarction cases (P<0.01). Conclusion: CVI-Q can be used for detecting cerebral hemodynamic changes and provide quantitative indexes for clinicians to estimate ischemia degree and treatment in cerebral infarction patients.
2.XBP-1 interacts with estrogen receptor alpha (ERalpha).
Li-Hua DING ; Qi-Nong YE ; Jing-Hua YAN ; Jian-Hua ZHU ; Qiu-Jun LÜ ; Zong-Hua WANG ; Cui-Fen HUANG
Chinese Journal of Biotechnology 2004;20(3):332-336
Estrogen receptor alpha (ERalpha) has been a primary target of treatment as well as a prognostic indicator for breast cancer. The level of human X-box binding protein 1 (XBP-1) mRNA was related with that of ERalpha in breast tumors and was over-expressed in some breast tumors. These previous studies suggested that XBP-1 may interact with ERalpha. XBP-1 has two isoforms, XBP-1S and XBP-1U, as the result of unique splicing. GST pull-down assay showed that both XBP-1S and XBP-1U bound to ERalpha in vitro. The binding of XBP-1S to ERalpha was stronger than that of XBP-1U to ERalpha. Co-immunoprecipitation revealed that the binding was in a ligand-independent manner. XBP-1S and XBP-1U interacted with the region of ERalpha that contains a DNA-binding domain. The ERalpha-interacting regions on XBP-1S and XBP-1U have been mapped to two regions, the N-terminal basic region leucine zipper domain (bzip) and the C-terminal activation domain. These findings suggest that XBP-1S and XBP-1U may participate in ERalpha signaling pathway through the mediation of ERalpha.
Breast Neoplasms
;
genetics
;
metabolism
;
Cell Line, Tumor
;
DNA-Binding Proteins
;
genetics
;
metabolism
;
Estrogen Receptor alpha
;
genetics
;
metabolism
;
Female
;
Humans
;
Protein Interaction Domains and Motifs
;
physiology
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Regulatory Factor X Transcription Factors
;
Signal Transduction
;
Transcription Factors
;
genetics
;
metabolism
;
X-Box Binding Protein 1
3.Mitochondrial DNA deletion mutations in articular chondrocytes of cartilage affected by osteoarthritis.
Hong-bin LÜ ; Yun ZHOU ; Jian-zhong HU ; Guang-hua LEI ; Min ZHU ; Kang-hua LI
Journal of Central South University(Medical Sciences) 2006;31(5):640-644
OBJECTIVE:
To detect the changes of mitochondrion DNA (mtDNA) sequence in articular chondrocytes of cartilage affected by osteoarthritis and to clarified the pathogenetic mechanism of osteoarthritis.
METHODS:
We analyzed the mtDNA 4,977 bp deletion mutations of articular chondrocytes in 10 patients with osteoarthritis and 3 normal cartilages using the gap-PCR amplification method. We designed a two round PCR detection method, in which total DNA was isolated from articular chondrocytes as the template of the first round PCR reaction and products from the first round were the template in the second round reaction.
RESULTS:
The results of the first rounds of PCR reaction showed the mtDNA 524 bp amplified products in the osteoarthritis group and in the corresponding peripheral blood samples were not detected, but the 533 bp products were detected. However,the results of the second round reaction revealed that the 524 bp zones were detected in 2 of the 10 osteoarthritis patients and the corresponding peripheral blood samples were not detected. The 533 bp products were detected in all specimens. The mtDNA 524 bp amplified products in all the normal articular chondrocytes and the corresponding peripheral white blood cells contrast were not detected in both rounds PCR.
CONCLUSION
This was the first study to evaluate the mtDNA 4799 bp large fragment deletion mutational accumulation between nt8,470 - nt13,447 of articular chondrocytes in osteoarthritic cartilage. Osteoarthritis may be related to mtDNA mutation of articular chondrocytes.
Adult
;
Cartilage, Articular
;
metabolism
;
pathology
;
Chondrocytes
;
metabolism
;
DNA, Mitochondrial
;
genetics
;
Female
;
Gene Deletion
;
Humans
;
Male
;
Middle Aged
;
Osteoarthritis
;
genetics
;
Osteoarthritis, Hip
;
genetics
;
Osteoarthritis, Knee
;
genetics
;
Sequence Analysis, DNA
4.Progress in the research of amorphous pharmaceuticals.
Jian YING ; Yang LÜ ; Guan-hua DU
Acta Pharmaceutica Sinica 2009;44(5):443-448
Amorphous is a special physical state of solid compounds that the positions of the molecules or atoms have no long-range order. Sometimes amorphous compounds have better bioavailability, or achieve ultra-fast absorption in situation of acute and intermittent symptoms than that of morphous compounds, thus change drug efficacy. Besides, different pharmaceutical preparing methods can lead to different characters. Research of amorphous compounds has been a hotspot, both in research field and industry world. However, there are challenges as amorphous compounds could be unstable; unexpected adverse drug reactions may also exist. In this review, recent progress in the research of amorphous pharmaceutical compounds both in the research field and the pharmaceutical industry is reviewed. Factors which can influence the efficacy of amorphous pharmaceuticals are summarized. The prospect of amorphous techniques is also discussed.
Absorption
;
Animals
;
Biological Availability
;
Chemistry, Pharmaceutical
;
Crystallization
;
Drug Stability
;
Humans
;
Pharmaceutical Preparations
;
chemistry
;
Solubility
;
Technology, Pharmaceutical
;
methods
5.Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
Yun LU ; Li-Qun WU ; Zheng-Hua LÜ ; Xin-Jian WANG ; Jing-Yang YANG
Chinese Medical Journal 2007;120(12):1042-1046
BACKGROUNDCancer-testis antigen (CTA) is a family of the most noticeable tumor antigens which could be potential tumor markers for cancer diagnosis. In this research we aimed to investigate the expression of SSX-1 and NY-ESO-1 mRNA, two members of the CTA family, in tissue and peripheral blood of patients with hepatocellular carcinoma (HCC) to assess their feasibility for the immunotherapy and diagnosis of HCC and the association of their expression levels with diverse clinical indicators.
METHODSThirty-six north Chinese patients with HCC and 30 normal controls were enrolled in this study. Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect the expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and corresponding levels in peripheral blood of patients.
RESULTSThe positive rates of SSX-1 and NY-ESO-1 mRNA expression were 61.1% (22/36) and 11.1% (4/36), respectively, in cancer tissues; 38.9% (14/36) and 5.6% (2/36), respectively, in the corresponding peripheral blood samples. No positive expression of either SSX-1 or NY-ESO-1 mRNA was detected in the samples of cancer-adjacent tissues, cirrhotic tissues, normal liver tissue or the peripheral blood of control patients. No significant relationship was found between the expression of these two genes and clinical indicators such as age, gender, tumor size, extent of differentiation, serum a-fetoprotein (AFP) level or infection with hepatitis B virus (P > 0.05). The short term recurrence rate was 46.2% (6/13) in patients whose peripheral blood expressed SSX-1 mRNA, while the recurrence rate in patients with negative SSX-1 mRNA was 28.6% (4/14).
CONCLUSIONSSSX-1 and NY-ESO-1 antigens might be new potentially promising targets for antigen-specific immunotherapy for HCC. High specific expression of SSX-1 and NY-ESO-1 mRNA suggested that we could apply them as tumor markers. The short term recurrence rate was significantly higher in patients whose peripheral blood expressed SSX-1 mRNA, suggesting that SSX-1 mRNA could be used as indicator for recurrence, metastasis and prognosis of HCC.
Adolescent ; Adult ; Aged ; Antigens, Neoplasm ; genetics ; Carcinoma, Hepatocellular ; metabolism ; Female ; Humans ; Liver Neoplasms ; metabolism ; Male ; Membrane Proteins ; genetics ; Middle Aged ; Neoplasm Proteins ; genetics ; Neoplastic Cells, Circulating ; RNA, Messenger ; analysis ; blood ; Repressor Proteins ; genetics ; Reverse Transcriptase Polymerase Chain Reaction
6.Epidemiological investigation on Wenchuan earthquake-struck trauma patients admitted to two hospitals of Chongqing.
Hua-sheng JIAN ; Zu-ming LÜ ; Yin-yan LI
Chinese Journal of Traumatology 2010;13(2):101-102
OBJECTIVETo study epidemiological characteristics and influential factors of in-hospital patients struck by the Wenchuan earthquake disaster.
METHODSThe clinical data of 196 cases were collected from 2 hospitals of Chongqing city, including age, sex, occupation, injury site, dwelling and injury severity score.
RESULTSIn this series, 31.63% victims'age was over 60 years, and 54.08% were farmers. Multiple trauma accounted for 35.71%, and lower limb injury for 33.67%. There was no significant difference on injury severity score between city dwellers and rural ones (P>0.05).
CONCLUSIONThe earthquake injury is influenced by many factors. More attention should be paid to the treatment at first 5 days after injury and high risk population.
Adult ; Aged ; China ; epidemiology ; Disasters ; statistics & numerical data ; Earthquakes ; statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Wounds and Injuries ; epidemiology
7.Characteristics of uterine contraction and stages of labor under continuous epidural block anesthesia.
Chun-yan YIN ; Jing-zhen ZHOU ; Xiao-yan LÜ ; Xiao-peng HUANG ; Gui-hua HE ; Jian-fei CHEN
Journal of Southern Medical University 2006;26(11):1563-1567
OBJECTIVETo observe the characteristics of uterine contraction and stages of labor during delivery under continuous epidural block anesthesia.
METHODSTotaling 213 parturients in spontaneous labor under epidural block anesthesia with dilated cervical orifice of 3 cm were monitored for the contraction cycle, duration, intensity and curve types of uterine contraction, and recordings were made for 30 min before and 30, 60 and 120 min after the anesthesia took effect, respectively. The duration of the active phase in the first, second and third stages of labor was compared between 421 cases with anesthesia and 237 without anesthesia.
RESULTSSignificant difference was noted in the objective indexes of uterine contraction recorded after anesthesia had taken effect (P<0.05) in comparison with those before anesthesia, suggesting significantly attenuated uterine contraction after anesthesia, whereas these indexes underwent no significant further variation as compared between different time points after anesthesia (P>0.05). The average active phase in the first stage was significantly shorter in anesthesia group than that in the control group (P<0.05), but the average duration of the second and third stages of labor differed little between the two groups with appropriate use of oxytocin under strict monitoring (P>0.05). The rates of obstetric forceps utilization and use of oxytocin were higher in anesthesia group than in the control group (P<0.05).
CONCLUSIONEpidural block anesthesia produces certain influences on uterine contraction and stages of labor during delivery, for which appropriate treatment measures may prove beneficial.
Adult ; Anesthesia, Epidural ; methods ; Anesthesia, Obstetrical ; methods ; Female ; Humans ; Labor, Obstetric ; physiology ; Pregnancy ; Time Factors ; Uterine Contraction ; drug effects ; Uterus ; drug effects ; physiology
8.Pharmacokinetics and metabolic disposition of exogenous phosphocreatine in rats.
Ling-Li ZOU ; Qiu-Sha LI ; Guo-Zhu HAN ; Li LÜ ; Heng XI ; Jian-Hua LI
Acta Pharmaceutica Sinica 2011;46(1):75-80
This article is report the study of the pharmacokinetics and metabolic disposition of exogenous phosphocreatine (PCr) in rats by means of an ion-pair HPLC-UV assay. PCr and its metabolite creatine (Cr) and related-ATP in rat plasma and red blood cell (RBC) were simultaneously determined. A blank plasma and RBC were initially run for baseline subtraction. Plasma and RBC samples were deproteinized with 6% PCA prior to HPLC. Following i.v. administration of PCr 500 mg x kg(-1) and 1 000 mg x kg(-1) the C-T curve could be described by the two-compartment model with t1/2beta 22.5-23.3 min, V(d) 0.956 4-0.978 6 L x kg(-1), CL 0.029 L. kg(-1) x min(-1). The Cr as PCr degraded product appeared as early as 2 min post i.v. dosing with t(max) 20 min, t1/2kappa (m) 40.6-42.7 min and f(m) 60%-76%. After po administration of PCr, the parent drug in plasma was undetectable, but the metabolite Cr was detected with t(max) 65-95 min, t1/2kappa (m) 56.0-57.7 min, metabolite-based bioavailability F(m) 55.02%-62.31%. PCr i.v. administration resulted in significant elevation of ATP level in RBC but not in plasma, the related-ATP in RBC was characterized by t(max) 68-83 min, t1/2kappa 49-52 min. In RBC no exogenous PCr was found but Cr was detected following i.v. administration of PCr, with the t(max) 120 min and t1/2k (m) 70 min for Cr. The above results indicate that PCr eliminates and bio-transforms in body very rapidly; K > K(m) confers ERL, instead of FRL, type upon the metabolic disposition of Cr. Following po administration of PCr, the degraded product Cr is absorbed but not the parent drug PCr. The formed Cr can be accounted for by most of i.v. and po PCr. Intravenous dosing leads apparently increased and sustained Cr and related-ATP concentration in RBC.
Adenosine Triphosphate
;
blood
;
pharmacokinetics
;
Administration, Oral
;
Animals
;
Area Under Curve
;
Biological Availability
;
Biotransformation
;
Cardiotonic Agents
;
administration & dosage
;
blood
;
pharmacokinetics
;
Creatine
;
administration & dosage
;
metabolism
;
pharmacokinetics
;
Erythrocytes
;
metabolism
;
Injections, Intravenous
;
Male
;
Phosphocreatine
;
administration & dosage
;
blood
;
pharmacokinetics
;
Rats
;
Rats, Sprague-Dawley
9.Expression of NF-kappaB mRNA in acute myeloid leukemia.
Min LIU ; Xu-Dong WEI ; Xiao-Dong LÜ ; Rui-Hua FAN ; Qing-Song YIN ; Jian ZHOU
Journal of Experimental Hematology 2010;18(2):359-362
This study was aimed to investigate the expression level of NF-kappaB mRNA in acute myeloid leukemia (AML) using real time fluorescence quantitative polymerase chain reduction (qPCR) detection and to explore the effect of NF-kappaB mRNA in pathogenesis of AML. The fresh bone marrow was collected from 60 newly diagnosed patients with AML, the total RNA was extracted by means of RTIzoL, the cDNA was synthesized, the expression of NF-kappaB mRNA was detected by qPCR using GAPDH as internal reference. 12 normal healthy persons were selected as controls. The results showed that the expression of NF-kappaB mRNA in patients with AML was higher than that in normal healthy persons with significant difference (p<0.05), the expression of NF-kappaB mRNA in patients with AML-M4 and -M5 were higher than that in patients with AML-M1, -M2 and -M3. It is concluded that the expression of NF-kappaB mRNA is higher in patients with AML. The up-regulation of NF-kappaB expression in patients with AML may play an important role in pathogenesis of AML.
Adolescent
;
Adult
;
Aged
;
Bone Marrow
;
metabolism
;
Case-Control Studies
;
Female
;
Humans
;
Leukemia, Myeloid, Acute
;
genetics
;
metabolism
;
pathology
;
Male
;
Middle Aged
;
NF-kappa B
;
genetics
;
metabolism
;
RNA, Messenger
;
genetics
;
Young Adult
10.Discussion of the cause and treatment on huge pseudo synovial cyst under the fascia lata.
Jian-Min LU ; Wang-Sheng LÜ ; Jin-Tu XIE ; Zhong-Sen HUA ; Jun CAI
China Journal of Orthopaedics and Traumatology 2012;25(2):168-169
Adult
;
Aged
;
Aged, 80 and over
;
Fascia Lata
;
surgery
;
Female
;
Humans
;
Male
;
Middle Aged
;
Synovial Cyst
;
surgery